Anxiety - Articles - Page 8 | CARLAT PUBLISHING

Buspirone: Still Effective After All These Years?

February 3, 2021

Eugene Rubin, MD. Psychiatrist in private practice, Bingham Farms, MI. Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Buspirone (Buspar) is approved for generalized anxiety disorder, but its efficacy there is often questioned. Here we find out how it stacks up against the benzos and SSRIs, and explore its off-label potential in depression, sexual dysfunction, alcoholism, traumatic brain injury, and premenstrual dysphoric disorder.

Rest Easy: Benzos, Z-Drugs, and Dementia

December 31, 2020

James Jenkins, MD.

James Jenkins, MD. Dr. Jenkins has disclosed that he has stock in Alkermes, Sage Therapeutics, Teva Pharmaceutical Industries, Trevena, and Viatris. Dr. Aiken has reviewed this article and has found no evidence of bias pertaining to this educational activity.

It may not be perfect, but this study has the best data yet on the controversial link between benzodiazepines and dementia.

The “Z-Drugs”: Safety Issues and Misuse Potential

June 10, 2020

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Once heralded for their relative safety compared to benzodiazepines, the “Z-drugs” are now known to be one of the most common causes of adverse drug events. Here we review the risks of Z-drugs and highlight updated dosing recommendations for zolpidem.

EXPERT Q&A

Benzodiazepines: Old Medicines, New Concerns

June 10, 2020

Kenneth Morford, MD

Kenneth Morford, MD
Assistant Professor and Program Director, Collaborative Behavioral Health & Addiction Medicine in Primary Care (CHAMP) at Yale School of Medicine. Dr. Morford has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Benzodiazepine use is on the rise, and is implicated with a significant portion of opioid-related overdose deaths. Dr. Morford gives the latest on benzodiazepine prevalence and suggests strategies to employ in addiction treatment settings when working with patients who use benzodiazepines.

Coronavirus and Mental Health - Part 1

March 6, 2020

This is a special episode covering coronavirus for mental health care professionals with a focus on children and adolescents. Dr. Feder discusses basic information on symptoms, minimizing transmission, tips for telepsychiatry, talking about the virus with patients prone to anxiety, and addressing cultural bias.Date published: 3/6/2020 Duration: 15 minutes, 11 secondsLinks and...

Research Theme Park: Anxiety

December 2, 2019

A ride through recent studies on anxiety, highlighting the playful and the practical. Why anxious people prefer to worry than relax. City parks lift mood, and a bike helmet changes the perception of risk. Anxious triggers are less distracting as we get older, and for a select group of patients...

Heart Rate Changes Linked to Emotional Dysregulation

November 21, 2019

Jess Levy, MD

Jess Levy, MD Dr. Levy has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Clinical psychiatry is becoming more attuned to the utility of tracking physiological markers of
regulation and dysregulation. The study clarifies where we are in understanding heart rate as a
clue in diagnosis and management.

Neuroticism and SSRIs

November 18, 2019

Neuroticism is not in the DSM, but it's a common cause of anxiety and may predict thether a patient respond to an SSRI. We talk with Nassir Ghaemi and bring you practical insights into this personality trait. How to recognize it, how to treat it, and how to avoid over-treating...

Does Trintellix Treat Generalized Anxiety?

November 11, 2019

Trintellix looks like a natural fit for anxiety disorders, with a serotonergic mechanism that overlaps with buspirone (5HT1a agonism). But things are not always as they seem in psychiatry. In this second installment of our anxiety series we delve into the failure of Trintellix in generalized anxiety disorder, and uncover...

A Scandalous History of Anxiety

November 4, 2019

Is Generalized Anxiety Disorder (GAD) an anxious temperament, a symptom of another disorder, or a valid disorder on its own? In Part One of our November series on anxiety, we trace the history of GAD from Sigmund Freud to DSM-5. With over two dozen choices, it isn't easy to pick...